These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 35504734)
1. The therapeutic prospect of zinc oxide nanoparticles in experimentally induced diabetic nephropathy. Abd El-Baset SA; Mazen NF; Abdul-Maksoud RS; Kattaia AAA Tissue Barriers; 2023 Jan; 11(1):2069966. PubMed ID: 35504734 [TBL] [Abstract][Full Text] [Related]
2. The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling. Abd El-Khalik SR; Nasif E; Arakeep HM; Rabah H Biol Trace Elem Res; 2022 Apr; 200(4):1677-1687. PubMed ID: 34241775 [TBL] [Abstract][Full Text] [Related]
3. Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice. Jiang Y; Liu J; Zhou Z; Liu K; Liu C Med Sci Monit; 2018 Oct; 24():7007-7014. PubMed ID: 30278036 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395 [TBL] [Abstract][Full Text] [Related]
5. Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats. Shukla R; Pandey N; Banerjee S; Tripathi YB Biomed Pharmacother; 2017 Sep; 93():276-285. PubMed ID: 28648975 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of chronic zinc oxide nanoparticles using on testicular damage in the streptozotocin-induced diabetic rat model. El-Behery EI; El-Naseery NI; El-Ghazali HM; Elewa YHA; Mahdy EAA; El-Hady E; Konsowa MMH Acta Histochem; 2019 Jan; 121(1):84-93. PubMed ID: 30413282 [TBL] [Abstract][Full Text] [Related]
7. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway. Guo M; Gao J; Jiang L; Dai Y Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175 [TBL] [Abstract][Full Text] [Related]
8. The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway. Liu L; Yang L; Chang B; Zhang J; Guo Y; Yang X Ren Fail; 2018 Nov; 40(1):492-497. PubMed ID: 30200803 [TBL] [Abstract][Full Text] [Related]
9. Exogenous spermine attenuates diabetic kidney injury in rats by inhibiting AMPK/mTOR signaling pathway. Zhang X; Zhang L; Chen Z; Li S; Che B; Wang N; Chen J; Xu C; Wei C Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33537831 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats. Hofni A; El-Moselhy MA; Taye A; Khalifa MM Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917 [TBL] [Abstract][Full Text] [Related]
11. Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathways. Awad AM; Elshaer SL; Gangaraju R; Abdelaziz RR; Nader MA Inflammopharmacology; 2024 Feb; 32(1):495-508. PubMed ID: 37498374 [TBL] [Abstract][Full Text] [Related]
12. Zinc oxide nanoparticles prevent the onset of diabetic nephropathy by inhibiting multiple pathways associated with oxidative stress. Padhye-Pendse A; Umrani R; Paknikar K; Jadhav S; Rajwade J Life Sci; 2024 Jun; 347():122667. PubMed ID: 38670449 [TBL] [Abstract][Full Text] [Related]
13. The KLF4-p62 axis prevents vascular endothelial cell injury via the mTOR/S6K pathway and autophagy in diabetic kidney disease. Wang X; Su W; Ma M; Zhu L; Gao R; Qin C; Shao S; Gao D; Gao J; Zhang Z Endokrynol Pol; 2022; 73(5):837-845. PubMed ID: 36621906 [TBL] [Abstract][Full Text] [Related]
14. Chen Y; Zheng YF; Lin XH; Zhang JP; Lin F; Shi H Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165163 [No Abstract] [Full Text] [Related]
15. Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy. Liu Y; Liu W; Zhang Z; Hu Y; Zhang X; Sun Y; Lei Q; Sun D; Liu T; Fan Y; Li H; Ding W; Fang J Ren Fail; 2021 Dec; 43(1):128-140. PubMed ID: 33427556 [TBL] [Abstract][Full Text] [Related]
16. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway. Zhu L; Han J; Yuan R; Xue L; Pang W Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956 [TBL] [Abstract][Full Text] [Related]
18. Secoisolariciresinol diglucoside in high-fat diet and streptozotocin-induced diabetic nephropathy in rats: a possible renoprotective effect. Sherif IO J Physiol Biochem; 2014 Dec; 70(4):961-9. PubMed ID: 25316298 [TBL] [Abstract][Full Text] [Related]
19. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes. Han J; Zhang Y; Shi X; Peng Z; Xing Y; Pang X J Tradit Chin Med; 2021 Feb; 41(1):125-132. PubMed ID: 33522205 [TBL] [Abstract][Full Text] [Related]
20. Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model. Qiao L; Liu Y; Li C; Ge J; Li T Pharmacology; 2019; 104(5-6):258-266. PubMed ID: 31344701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]